Predicting Drug‐Induced Hepatotoxicity: In Vitro, In Silico and In Vivo Approaches

[1]  Dmitri B Papkovsky,et al.  Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Sten Orrenius,et al.  Mitochondria, oxidative stress and cell death , 2007, Apoptosis.

[3]  D. Pessayre,et al.  Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. , 1991, The Journal of pharmacology and experimental therapeutics.

[4]  Munir Pirmohamed,et al.  The role of metabolic activation in drug-induced hepatotoxicity. , 2005, Annual review of pharmacology and toxicology.

[5]  Richard J. Thompson,et al.  Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. , 2008, Gastroenterology.

[6]  B. Gazzard,et al.  Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors , 2002, AIDS.

[7]  A. Belló-Klein,et al.  Oxidative stress, hepatocellular integrity, and hepatic function after initial reperfusion in human hepatic transplantation. , 2004, Transplantation proceedings.

[8]  A. Starkov,et al.  Mitochondrial targets of drug toxicity. , 2000, Annual review of pharmacology and toxicology.

[9]  D. Larrey,et al.  Microvesicular steatosis after ketoprofen administration , 1991 .

[10]  J. Dykens,et al.  Assessment of mitochondrial membrane potential in situ using single potentiometric dyes and a novel fluorescence resonance energy transfer technique. , 2001, Methods in Cell Biology.

[11]  P. Reiss,et al.  Infection with HIV-1 induces a decrease in mtDNA. , 2005, The Journal of infectious diseases.

[12]  R. Krauss,et al.  When good drugs go bad , 2007, Nature.

[13]  M. Paiva,et al.  Increased serum bile acids as a possible biomarker of hepatotoxicity in Brazilian workers exposed to solvents in car repainting shops , 2005 .

[14]  E. Timmermans,et al.  Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells. , 2007, Antiviral research.

[15]  Paul B Watkins,et al.  Idiosyncratic Liver Injury: Challenges and Approaches , 2005, Toxicologic pathology.

[16]  J. Dykens,et al.  Drug-Induced Mitochondrial Dysfunction , 2008 .

[17]  Mark D. Johnson,et al.  Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression. , 2007, Chemical research in toxicology.

[18]  B. Hendriks,et al.  Multiple effects of acetaminophen and p38 inhibitors: Towards pathway toxicology , 2008, FEBS letters.

[19]  C. Laggner,et al.  Why drugs fail--a study on side effects in new chemical entities. , 2005 .

[20]  J. Stables,et al.  Stability and comparative metabolism of selected felbamate metabolites and postulated fluorofelbamate metabolites by postmitochondrial suspensions. , 2005, Chemical research in toxicology.

[21]  D. Pessayre,et al.  Hepatotoxicity due to mitochondrial dysfunction , 2004, Cell Biology and Toxicology.

[22]  M. Mattson,et al.  The Identity and Regulation of the Mitochondrial Permeability Transition Pore , 2008, Annals of the New York Academy of Sciences.

[23]  Yuichi Sugiyama,et al.  Inhibition of Bile Acid Transport across Na+/Taurocholate Cotransporting Polypeptide (SLC10A1) and Bile Salt Export Pump (ABCB 11)-Coexpressing LLC-PK1 Cells by Cholestasis-Inducing Drugs , 2006, Drug Metabolism and Disposition.

[24]  Silvio Albertini,et al.  Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  O. Fardel,et al.  Regulation of biliary drug efflux pump expression by hormones and xenobiotics. , 2001, Toxicology.

[26]  R. Temple,et al.  Hy's law: predicting serious hepatotoxicity , 2006, Pharmacoepidemiology and drug safety.

[27]  P. Meier,et al.  Hepatobiliary transporters and drug‐induced cholestasis , 2006, Hepatology.

[28]  G. Cruciani,et al.  MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. , 2005, Journal of medicinal chemistry.

[29]  P. Meier,et al.  Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury , 2007, Pharmacogenetics and genomics.

[30]  P. Harrigan,et al.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. , 2002, The New England journal of medicine.

[31]  Yeong Shik Kim,et al.  Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. , 2007, Biological & pharmaceutical bulletin.

[32]  S. Frostick,et al.  Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  S. K. Pandian,et al.  Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes. , 2007, Basic & clinical pharmacology & toxicology.

[34]  G. Labbe,et al.  Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. , 1991, Biochemical pharmacology.

[35]  R. Robertson,et al.  Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. , 2003, Diabetes.

[36]  U. Andersson,et al.  Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies. , 2007, Archives of biochemistry and biophysics.

[37]  Olivier Fardel,et al.  Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.

[38]  U. Boelsterli,et al.  Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  D. Grant,et al.  Molecular mechanism of slow acetylation of drugs and carcinogens in humans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  B. Martin,et al.  Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Gorman,et al.  The reaction of cysteine and related compounds with penicillins and cephalosporins. , 1971, The Journal of antibiotics.

[42]  K. Penttilä,et al.  Effects of entacapone and tolcapone on mitochondrial membrane potential. , 2002, European journal of pharmacology.

[43]  K. Nakagawa,et al.  Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity. , 2007, Pharmacogenomics.

[44]  Michael Roden,et al.  Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I , 2004, Journal of Pharmacology and Experimental Therapeutics.

[45]  Yvonne Will,et al.  Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  N. Buckley,et al.  Should a Lower Treatment Line Be Used When Treating Paracetamol Poisoning in Patients with Chronic Alcoholism? , 2002, Drug safety.

[47]  V. Tayal,et al.  Hepatoprotective effect of tocopherol against isoniazid and rifampicin induced hepatotoxicity in albino rabbits. , 2007, Indian journal of experimental biology.

[48]  C. Pang,et al.  MtDNA mutations, functional decline and turnover of mitochondria in aging. , 2008, Frontiers in bioscience : a journal and virtual library.

[49]  Ernesto Callegari,et al.  A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.

[50]  U. Boelsterli,et al.  Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity? , 2007, Toxicology and applied pharmacology.

[51]  M. Hammami,et al.  Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. , 2007, Life sciences.

[52]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[53]  J. Bravo,et al.  Fatty liver and pleural effusion with ibuprofen therapy. , 1977, Annals of internal medicine.

[54]  Timothy D Veenstra,et al.  Serum and plasma proteomics. , 2007, Chemical reviews.

[55]  H. Takikawa.  Hepatobiliary transport of bile acids and organic anions. , 2002, Journal of hepato-biliary-pancreatic surgery.

[56]  N. Nalini,et al.  Antioxidant effect of 2‐hydroxy‐4‐methoxy benzoic acid on ethanol‐induced hepatotoxicity in rats , 2007, The Journal of pharmacy and pharmacology.

[57]  P. Beaune,et al.  Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug. , 1992, Molecular pharmacology.

[58]  K. Wallace,et al.  The effect of peroxisome proliferators on mitochondrial bioenergetics. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[59]  F. Van hoof,et al.  In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions. , 1992, Biochemical pharmacology.

[60]  B. Golding,et al.  2,6-diarylaminotetrahydropyrans from reactions of glutaraldehyde with anilines: models for biomolecule cross-linking. , 2004, Chemical research in toxicology.

[61]  M. Miller,et al.  Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[62]  Stephen Kim,et al.  Drug-Induced Liver Injury: Review Article , 2007, Digestive Diseases and Sciences.

[63]  S. Lautraite,et al.  Optimisation of cell-based assays for medium throughput screening of oxidative stress. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[64]  J. Senior,et al.  Drug-related hepatotoxicity. , 2006, The New England journal of medicine.

[65]  J. Mallolas,et al.  Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine , 2004, Hepatology.

[66]  L. Van Haute,et al.  Linezolid-induced inhibition of mitochondrial protein synthesis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  C. D. Thompson,et al.  Mechanisms of idiosyncratic drug reactions: the case of felbamate. , 2002, Chemico-biological interactions.

[68]  J. Muntané,et al.  Dual effect of ethanol on cell death in primary culture of human and rat hepatocytes. , 2004, Alcohol and alcoholism.

[69]  V. Meador,et al.  Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies. , 2005, Veterinary clinical pathology.

[70]  J. Uetrecht,et al.  Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. , 2002, Current drug metabolism.

[71]  P. Beaune,et al.  Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9. , 1996, Molecular pharmacology.

[72]  L. Babiss,et al.  Toxicogenomics in predictive toxicology in drug development. , 2004, Chemistry & biology.

[73]  Thomas Hartung,et al.  Meeting Report: Validation of Toxicogenomics-Based Test Systems: ECVAM–ICCVAM/NICEATM Considerations for Regulatory Use , 2005, Environmental health perspectives.

[74]  N. Kamo,et al.  Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state , 1979, The Journal of Membrane Biology.

[75]  A. Y. Lu,et al.  N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[77]  Albert P. Li,et al.  A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity. , 2002, Chemico-biological interactions.

[78]  Carl Alden,et al.  Biomarkers to monitor drug-induced phospholipidosis. , 2007, Toxicology and applied pharmacology.

[79]  D. Amacher.  Drug-associated mitochondrial toxicity and its detection. , 2005, Current medicinal chemistry.

[80]  M. Uysal,et al.  Melatonin improved the disturbances in hepatic prooxidant and antioxidant balance and hepatotoxicity induced by a high cholesterol diet in C57BL/6J mice. , 2004, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[81]  Christian Skonberg,et al.  Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: correlation to in vitro drug metabolism. , 2007, Chemical research in toxicology.

[82]  S. Eckenrode,et al.  The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. , 2006, Vascular pharmacology.

[83]  Xuanhong Zhang,et al.  Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms. , 2008, Toxicology.

[84]  J. Ou,et al.  Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[85]  T. Bauer,et al.  Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy , 1997, European journal of immunology.

[86]  Paul B Watkins,et al.  Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity , 2007, Journal of Pharmacology and Experimental Therapeutics.

[87]  G. Merényi,et al.  The chemistry of peroxynitrite: implications for biological activity. , 2008, Methods in enzymology.

[88]  P. Meier,et al.  The bile salt export pump , 2007, Pflügers Archiv - European Journal of Physiology.

[89]  E. Eger,et al.  Biotransformation of Halothane, Enflurane, Isoflurane, and Desflurane to Trifluoroacetylated Liver Proteins: Association Between Protein Acylation and Hepatic Injury , 1997, Anesthesia and analgesia.

[90]  P. Beaune,et al.  Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. , 1990, The Journal of clinical investigation.

[91]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.

[92]  E. Zafrani,et al.  Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. , 1999, Journal of hepatology.

[93]  N. Kaplowitz.  Rules and laws of drug hepatotoxicity , 2006, Pharmacoepidemiology and drug safety.

[94]  R. Sokol,et al.  "Let there be bile"--understanding hepatic injury in cholestasis. , 2006, Journal of pediatric gastroenterology and nutrition.

[95]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.

[96]  S. Ramaiah.  A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[97]  T. Baillie,et al.  Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.

[98]  A. Kalgutkar,et al.  Minimising the potential for metabolic activation in drug discovery , 2005, Expert opinion on drug metabolism & toxicology.

[99]  T. Gunter,et al.  Glucagon effects on the membrane potential and calcium uptake rate of rat liver mitochondria. , 1984, The Journal of biological chemistry.

[100]  S. Mallal,et al.  HLA-B*5701 screening for hypersensitivity to abacavir. , 2008, The New England journal of medicine.

[101]  J. Lott,et al.  Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. , 2000, Clinical chemistry.

[102]  J. Uetrecht.  Idiosyncratic drug reactions: past, present, and future. , 2008, Chemical research in toxicology.

[103]  R. Paules,et al.  Phenotypic anchoring: linking cause and effect. , 2003, Environmental health perspectives.

[104]  A. Lafeuillade,et al.  Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection , 2001, The Lancet.

[105]  D. Pessayre,et al.  NASH: a mitochondrial disease. , 2005, Journal of hepatology.

[106]  M. Tomita,et al.  Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption* , 2006, Journal of Biological Chemistry.

[107]  John C. Dearden,et al.  In silico prediction of drug toxicity , 2003, J. Comput. Aided Mol. Des..

[108]  R. Moreno-Sánchez,et al.  Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart. , 1999, Biochemical pharmacology.

[109]  J. Manautou,et al.  Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease , 2007, Toxicologic pathology.

[110]  A. Kalgutkar,et al.  NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine. , 2007, Chemical research in toxicology.

[111]  Elaine Holmes,et al.  The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.

[112]  K. Tolman.  The liver and lovastatin. , 2002, The American journal of cardiology.

[113]  C. Alden,et al.  Drug safety evaluation through biomarker analysis--a toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer. , 2007, Toxicology and applied pharmacology.

[114]  Jiang Li,et al.  Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection. , 2007, Methods in molecular biology.

[115]  J. Idle,et al.  Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice* , 2008, Journal of Biological Chemistry.

[116]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[117]  Diana Kazolias,et al.  Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport , 2006, Drug Metabolism and Disposition.

[118]  J. Xu,et al.  In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[119]  V. Balasubramaniyan,et al.  Role of leptin on alcohol-induced oxidative stress in Swiss mice. , 2003, Pharmacological research.

[120]  T. Hartung,et al.  Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. , 2006, Chemical research in toxicology.

[121]  C. McClain,et al.  Diverse antioxidants protect against acetaminophen hepatotoxicity , 2005, Journal of biochemical and molecular toxicology.

[122]  M. Moura,et al.  JAUNDICE ASSOCIATED WITH NAPROXEN , 1980, Postgraduate medical journal.

[123]  R. Capaldi,et al.  Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. , 2007, Toxicology and applied pharmacology.

[124]  N. Avadhani,et al.  Physiological Role of the N-terminal Processed P4501A1 Targeted to Mitochondria in Erythromycin Metabolism and Reversal of Erythromycin-mediated Inhibition of Mitochondrial Protein Synthesis* , 1999, The Journal of Biological Chemistry.

[125]  D. Pessayre,et al.  Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. , 1994, The Journal of pharmacology and experimental therapeutics.

[126]  R. Townsend,et al.  Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. , 2005, Clinical chemistry.

[127]  S. Bhattacharyya,et al.  Black tea-induced amelioration of hepatic oxidative stress through antioxidative activity in EAC-bearing mice. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[128]  C. Girish,et al.  Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. , 2006, The Indian journal of medical research.

[129]  Ivan Rusyn,et al.  Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[130]  T. Baillie,et al.  Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. , 2001, Chemical research in toxicology.

[131]  M. Moroni,et al.  [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. , 2005, Journal of Antimicrobial Chemotherapy.

[132]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[133]  F. Schmitz,et al.  13C-Methionine Breath Test Detects Distinct Hepatic Mitochondrial Dysfunction in HIV-Infected Patients With Normal Serum Lactate , 2005, Journal of acquired immune deficiency syndromes.

[134]  Li Liang,et al.  Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS). , 2005, Chemical research in toxicology.

[135]  Hiroshi Yamada,et al.  In vivo hepatotoxicity study of rats in comparison with in vitro hepatotoxicity screening system. , 2006, The Journal of toxicological sciences.

[136]  P. Kaheinen,et al.  Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production. , 1997, European journal of pharmacology.

[137]  R. Ulrich,et al.  Idiosyncratic toxicity: a convergence of risk factors. , 2007, Annual review of medicine.

[138]  T. Macdonald,et al.  In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity. , 2003, Chemical research in toxicology.